FF
Fairmount Funds Management LLC disclosed a 20% stake in MTRI
Fairmount Funds Management LLC reported owning 20% of InMed Pharmaceuticals Inc. (MTRI) (10,555,507 shares) in a Schedule 13D filed Nov 12, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Nov 12, 2026
- Source
- Schedule 13D